{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:56Z","timestamp":1791560996524,"version":"4.3.4"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04569-1","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:21:36Z","timestamp":1791552096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EML4\u2013ALK fusion rewires transcriptomic, miRNA, and CAF-associated programs in non-small cell lung cancer"],"prefix":"10.1007","author":[{"given":"Divya","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-1338","authenticated-orcid":false,"given":"Ekta","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8559-5258","authenticated-orcid":false,"given":"Rajeev","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"4569_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun. 2014;5:4846.","journal-title":"Nat Commun"},{"key":"4569_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02161-7","volume":"10","author":"SV Liu","year":"2025","unstructured":"Liu SV, Nagasaka M, Atz J, Solca F, M\u00fcllauer L. Oncogenic gene fusions in cancer: from biology to therapy. Signal Transduct Target Ther. 2025;10:111.","journal-title":"Signal Transduct Target Ther"},{"key":"4569_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4\u2013ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561\u20136.","journal-title":"Nature"},{"key":"4569_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RAJc. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"4569_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02129-7","volume":"10","author":"R Nussinov","year":"2025","unstructured":"Nussinov R, Yavuz BR, Jang H. Molecular principles underlying aggressive cancers. Signal Transduct Target Ther. 2025;10:42.","journal-title":"Signal Transduct Target Ther"},{"key":"4569_CR6","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.18632\/oncotarget.14298","volume":"8","author":"H Kim","year":"2016","unstructured":"Kim H, Yang JM, Jin Y, Jheon S, Kim K, Lee CT, et al. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status. Oncotarget. 2016;8:8484.","journal-title":"Oncotarget"},{"key":"4569_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","volume":"13","author":"S-L Yu","year":"2008","unstructured":"Yu S-L, Chen H-Y, Chang G-C, Chen C-Y, Chen H-W, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13:48\u201357.","journal-title":"Cancer Cell"},{"key":"4569_CR8","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1073\/pnas.1520329112","volume":"112","author":"P Gasparini","year":"2015","unstructured":"Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, et al. MicroRNA classifiers are powerful diagnostic\/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proc Natl Acad Sci U S A. 2015;112:14924\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4569_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1415801","volume":"14","author":"T Mohammad","year":"2024","unstructured":"Mohammad T, Zolotovskaia MA, Suntsova MV, Buzdin AA. Cancer fusion transcripts with human non-coding RNAs. Front Oncol. 2024;14:1415801.","journal-title":"Front Oncol"},{"key":"4569_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.33972","volume":"151","author":"V Hafsta\u00f0","year":"2022","unstructured":"Hafsta\u00f0 V, S\u00f8kilde R, H\u00e4kkinen J, Larsson M, Vallon\u2010Christersson J, Rovira C, et al. Regulatory networks and 5\u2032 partner usage of miRNA host gene fusions in breast cancer. Int J Cancer. 2022;151:95\u2013106.","journal-title":"Int J Cancer"},{"key":"4569_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04065-0","volume":"12","author":"B Lu","year":"2021","unstructured":"Lu B, Jiang R, Xie B, Wu W, Zhao Y. Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapy. Cell Death Dis. 2021;12:783.","journal-title":"Cell Death Dis"},{"key":"4569_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002557","volume":"3","author":"X Wang","year":"2008","unstructured":"Wang X, Tang S, Le S-Y, Lu R, Rader JS, Meyers C, et al. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE. 2008;3:e2557.","journal-title":"PLoS ONE"},{"key":"4569_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbrc.2009.08.044","volume":"388","author":"Q Yao","year":"2009","unstructured":"Yao Q, Xu H, Zhang Q-Q, Zhou H, Qu L-H. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun. 2009;388:539\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"4569_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/nsmb.1921","volume":"17","author":"M Thomas","year":"2010","unstructured":"Thomas M, Lieberman J, Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol. 2010;17:1169\u201374.","journal-title":"Nat Struct Mol Biol"},{"key":"4569_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264645","volume":"17","author":"H Liu","year":"2022","unstructured":"Liu H, Li T, Dong C, Lyu J. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma. PLoS ONE. 2022;17:e0264645.","journal-title":"PLoS ONE"},{"key":"4569_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9719723","author":"T Wu","year":"2019","unstructured":"Wu T, Hu H, Zhang T, Jiang L, Li X, Liu S, et al. miR-25 promotes cell proliferation, migration, and invasion of non-small-cell lung cancer by targeting the LATS2\/YAP signaling pathway. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/9719723.","journal-title":"Oxid Med Cell Longev"},{"key":"4569_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ctd2.352","volume":"4","author":"Y Chang","year":"2024","unstructured":"Chang Y, Zhao Z, Song Y. Research progress on fusion genes in tumours. Clin Transl Discov. 2024;4:e352.","journal-title":"Clin Transl Discov"},{"key":"4569_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/gad.1540407","volume":"21","author":"YS Lee","year":"2007","unstructured":"Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025\u201330.","journal-title":"Genes Dev"},{"key":"4569_CR19","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1137999","volume":"315","author":"C Mayr","year":"2007","unstructured":"Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007;315:1576\u20139.","journal-title":"Science"},{"key":"4569_CR20","doi-asserted-by":"crossref","unstructured":"Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, et al. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. J clin investig. 2013;123.","DOI":"10.1172\/JCI67144"},{"key":"4569_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"4569_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864739","volume":"13","author":"J-Y Mun","year":"2022","unstructured":"Mun J-Y, Leem S-H, Lee JH, Kim HS. Dual relationship between stromal cells and immune cells in the tumor microenvironment. Front Immunol. 2022;13:864739.","journal-title":"Front Immunol"},{"key":"4569_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-031210-101357","volume":"29","author":"R Roozendaal","year":"2011","unstructured":"Roozendaal R, Mebius RE. Stromal cell\u2013immune cell interactions. Annu Rev Immunol. 2011;29:23\u201343.","journal-title":"Annu Rev Immunol"},{"key":"4569_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03293-6","volume":"24","author":"A Zabeti Touchaei","year":"2024","unstructured":"Zabeti Touchaei A, Vahidi S. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1\/PD-L1 and CTLA-4 pathways. Cancer Cell Int. 2024;24:102.","journal-title":"Cancer Cell Int"},{"key":"4569_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijtm4010003","volume":"4","author":"H Schwarzenbach","year":"2024","unstructured":"Schwarzenbach H. Clinical implementation of microRNAs in cancer immunology. Intern J Transl Med. 2024;4:53\u201371.","journal-title":"Intern J Transl Med"},{"key":"4569_CR26","doi-asserted-by":"publisher","first-page":"1378302","DOI":"10.3389\/fcell.2024.1378302","volume":"12","author":"Z Gou","year":"2024","unstructured":"Gou Z, Li J, Liu J, Yang N, Biology D. The hidden messengers: cancer associated fibroblasts\u2014derived exosomal miRNAs as key regulators of cancer malignancy. Frontiers in Cell. 2024;12:1378302.","journal-title":"Frontiers in Cell"},{"key":"4569_CR27","doi-asserted-by":"crossref","first-page":"D817","DOI":"10.1093\/nar\/gkz1018","volume":"48","author":"YE Jang","year":"2020","unstructured":"Jang YE, Jang I, Kim S, Cho S, Kim D, Kim K, et al. ChimerDB 4.0: an updated and expanded database of fusion genes. Nucleic Acids Res. 2020;48:D817\u201324.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.sedgeo.2016.01.009","volume":"336","author":"P Vermeesch","year":"2016","unstructured":"Vermeesch P, Resentini A, Garzanti EJSG. An R package for statistical provenance analysis. Sediment Geol. 2016;336:14\u201325.","journal-title":"Sediment Geol"},{"key":"4569_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea S, Josse J, Husson FJJoss. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25:1\u201318.","journal-title":"J Stat Softw"},{"key":"4569_CR30","unstructured":"Blighe K, Rana S, Lewis M. EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling. R package version. 2019;1:10.18129."},{"key":"4569_CR31","doi-asserted-by":"crossref","unstructured":"Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim RJBb. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC bioinformatics. 2015;16:1\u20137.","DOI":"10.1186\/s12859-015-0611-3"},{"key":"4569_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","volume":"27","author":"ME Smoot","year":"2011","unstructured":"Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker TJB. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27:431\u20132.","journal-title":"Bioinformatics"},{"key":"4569_CR33","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-YJBSB. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:1\u20137.","journal-title":"BMC Syst Biol"},{"key":"4569_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-60761-987-1_18","volume-title":"Data mining in proteomics: from standards to applications","author":"M Kohl","year":"2011","unstructured":"Kohl M, Wiese S, Warscheid B. Cytoscape: software for visualization and analysis of biological networks. In: Data mining in proteomics: from standards to applications. 2011. p. 291\u2013303."},{"key":"4569_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, et al. The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007;8:1\u201316.","journal-title":"Genome Biol"},{"key":"4569_CR37","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Goto SJNar. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research. 2000;28:27\u201330.","DOI":"10.1093\/nar\/28.1.27"},{"key":"4569_CR38","doi-asserted-by":"crossref","unstructured":"Wilkinson L. ggplot2: elegant graphics for data analysis by Wickham, H. Oxford University Press; 2011.","DOI":"10.1111\/j.1541-0420.2011.01616.x"},{"key":"4569_CR39","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"4569_CR40","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4569_CR41","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:D155\u201362.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR42","doi-asserted-by":"publisher","first-page":"D360","DOI":"10.1093\/nar\/gkx1144","volume":"46","author":"T Tokar","year":"2018","unstructured":"Tokar T, Pastrello C, Rossos AE, Abovsky M, Hauschild A-C, Tsay M, et al. MirDIP 4.1\u2014integrative database of human microRNA target predictions. Nucleic Acids Res. 2018;46:D360\u201370.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR43","doi-asserted-by":"publisher","first-page":"W451","DOI":"10.1093\/nar\/gkl243","volume":"34","author":"J Kr\u00fcger","year":"2006","unstructured":"Kr\u00fcger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006;34:W451\u20134.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR44","first-page":"790","volume":"1","author":"R Kolde","year":"2015","unstructured":"Kolde R, Kolde MR. Package \u2018pheatmap.\u2019 R package version. 2015;1:790.","journal-title":"R package version"},{"key":"4569_CR45","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"Consortium U","year":"2019","unstructured":"Consortium U. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506\u201315.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrg3462","volume":"14","author":"G Meister","year":"2013","unstructured":"Meister G. Argonaute proteins: functional insights and emerging roles. Nat Rev Genet. 2013;14:447\u201359.","journal-title":"Nat Rev Genet"},{"key":"4569_CR47","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493\u2013500.","journal-title":"Nature"},{"key":"4569_CR48","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u201312.","journal-title":"J Comput Chem"},{"key":"4569_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05428-4","volume":"24","author":"J Scire","year":"2023","unstructured":"Scire J, Huisman JS, Grosu A, Angst DC, Lison A, Li J, et al. EstimateR: an R package to estimate and monitor the effective reproductive number. BMC Bioinformatics. 2023;24:310.","journal-title":"BMC Bioinformatics"},{"key":"4569_CR50","first-page":"1","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:1\u201320.","journal-title":"Genome Biol"},{"key":"4569_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-0716-0327-7_16","volume-title":"Bioinformatics for cancer immunotherapy: methods protocols","author":"G Sturm","year":"2020","unstructured":"Sturm G, Finotello F, List M. Immunedeconv: an R package for unified access to computational methods for estimating immune cell fractions from bulk RNA-sequencing data. In: Bioinformatics for cancer immunotherapy: methods protocols. 2020. p. 223\u201332."},{"key":"4569_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cellimm.2007.01.012","volume":"244","author":"C Ortutay","year":"2006","unstructured":"Ortutay C, Vihinen M. Immunome: a reference set of genes and proteins for systems biology of the human immune system. Cell Immunol. 2006;244:87\u20139.","journal-title":"Cell Immunol"},{"key":"4569_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sdata.2018.15","volume":"5","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya S, Dunn P, Thomas CG, Smith B, Schaefer H, Chen J, et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data. 2018;5:1\u20139.","journal-title":"Sci Data"},{"key":"4569_CR54","volume":"56","author":"T Wei","year":"2017","unstructured":"Wei T, Simko V, Levy M, Xie Y, Jin Y, Zemla J. Package \u2018corrplot.\u2019 Statistician. 2017;56:e24.","journal-title":"Statistician"},{"key":"4569_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:1\u20138.","journal-title":"BMC Bioinformatics"},{"issue":"1437\u201352","key":"4569_CR56","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell Death Differ. 2017;171(1437\u201352):e17.","journal-title":"Cell Death Differ"},{"key":"4569_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115166","author":"AA Mohamed","year":"2025","unstructured":"Mohamed AA, Wang PY, Bartel DP, Vos SM. The structural basis for RNA slicing by human Argonaute2. Cell Rep. 2025. https:\/\/doi.org\/10.1016\/j.celrep.2024.115166.","journal-title":"Cell Rep"},{"key":"4569_CR58","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.7150\/ijbs.109803","volume":"21","author":"Z Niu","year":"2025","unstructured":"Niu Z, He J, Wang S, Xue B, Zhang H, Hou R, et al. Targeting glycolysis for treatment of breast cancer resistance: current progress and future prospects. Int J Biol Sci. 2025;21:2589.","journal-title":"Int J Biol Sci"},{"key":"4569_CR59","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1002\/jcb.24173","volume":"113","author":"JCM de\u2010 Freitas\u2010Junior","year":"2012","unstructured":"de\u2010 Freitas\u2010Junior JCM, Bastos LG, Freire\u2010Neto CA, Rocher BD, Abdelhay ESFW, Morgado\u2010D\u00edaz JA. N\u2010glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells. J Cell Biochem. 2012;113:2957\u201366.","journal-title":"J Cell Biochem"},{"key":"4569_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146945","volume":"6","author":"K \u0160\u010dup\u00e1kov\u00e1","year":"2021","unstructured":"\u0160\u010dup\u00e1kov\u00e1 K, Adelaja OT, Balluff B, Ayyappan V, Tressler CM, Jenkinson NM, et al. Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis. JCI Insight. 2021;6:e146945.","journal-title":"JCI Insight"},{"key":"4569_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9090118","volume":"9","author":"SR Sabir","year":"2017","unstructured":"Sabir SR, Yeoh S, Jackson G, Bayliss RJC. EML4-ALK variants: biological and molecular properties, and the implications for patients. Cancers. 2017;9:118.","journal-title":"Cancers"},{"key":"4569_CR62","doi-asserted-by":"crossref","unstructured":"Bayliss R, Choi J, Fennell DA, Fry AM, Richards MWJC, sciences ml. Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cellular molecular life sciences. 2016;73:1209\u201324.","DOI":"10.1007\/s00018-015-2117-6"},{"key":"4569_CR63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.lungcan.2020.09.012","volume":"149","author":"H Tao","year":"2020","unstructured":"Tao H, Shi L, Zhou A, Li H, Gai F, Huang Z, et al. Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer. Lung Cancer. 2020;149:154\u201361.","journal-title":"Lung Cancer"},{"key":"4569_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.chembiol.2021.05.007","volume":"29","author":"SA Malaker","year":"2022","unstructured":"Malaker SA, Quanico J, Raffo-Romero A, Kobeissy F, Aboulouard S, Tierny D, et al. On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape. Cell Chem Biol. 2022;29:30-42. e4.","journal-title":"Cell Chem Biol"},{"key":"4569_CR65","doi-asserted-by":"crossref","unstructured":"Dong X-M, Chen L, Xu Y-X, Wu P, Xie T, Liu Z-Q. Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies. Cancer Gene Therapy. 2025:1\u201319.","DOI":"10.1038\/s41417-024-00858-5"},{"key":"4569_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2374","volume":"8","author":"HL Roderick","year":"2008","unstructured":"Roderick HL, Cook SJ. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer. 2008;8:361\u201375.","journal-title":"Nat Rev Cancer"},{"key":"4569_CR67","doi-asserted-by":"publisher","first-page":"15225","DOI":"10.1073\/pnas.1103315108","volume":"108","author":"Y-F Chen","year":"2011","unstructured":"Chen Y-F, Chiu W-T, Chen Y-T, Lin P-Y, Huang H-J, Chou C-Y, et al. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci U S A. 2011;108:15225\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4569_CR68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41591-018-0323-0","volume":"25","author":"VH Teixeira","year":"2019","unstructured":"Teixeira VH, Pipinikas CP, Pennycuick A, Lee-Six H, Chandrasekharan D, Beane J, et al. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions. Nat Med. 2019;25:517\u201325.","journal-title":"Nat Med"},{"key":"4569_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01766","volume":"10","author":"AL Parker","year":"2020","unstructured":"Parker AL, Cox TR. The role of the ECM in lung cancer dormancy and outgrowth. Front Oncol. 2020;10:567139.","journal-title":"Front Oncol"},{"key":"4569_CR70","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jtho.2016.01.015","volume":"11","author":"RM Bremnes","year":"2016","unstructured":"Bremnes RM, Busund L-T, Kilv\u00e6r TL, Andersen S, Richardsen E, Paulsen EE, et al. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non\u2013small cell lung cancer. J Thorac Oncol. 2016;11:789\u2013800.","journal-title":"J Thorac Oncol"},{"key":"4569_CR71","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/1541-7786.MCR-14-0155","volume":"13","author":"M Puig","year":"2015","unstructured":"Puig M, Lugo R, Gabasa M, Gim\u00e9nez A, Vel\u00e1squez A, Galgoczy R, et al. Matrix stiffening and \u03b21 integrin drive subtype-specific fibroblast accumulation in lung cancer. Mol Cancer Res. 2015;13:161\u201373.","journal-title":"Mol Cancer Res"},{"key":"4569_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00745-7","volume":"13","author":"Z Liu","year":"2025","unstructured":"Liu Z, Zhang X, Ben T, Li M, Jin Y, Wang T, et al. Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets. Biomark Res. 2025;13:38.","journal-title":"Biomark Res"},{"key":"4569_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3953-6","volume":"18","author":"CJ Lovitt","year":"2018","unstructured":"Lovitt CJ, Shelper TB, Avery VM. Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer. 2018;18:1\u201311.","journal-title":"BMC Cancer"},{"key":"4569_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168782","volume":"22","author":"Y Wang","year":"2021","unstructured":"Wang Y, Shi J, Tong X. Cross-talk between mechanosensitive ion channels and calcium regulatory proteins in cardiovascular health and disease. Int J Mol Sci. 2021;22:8782.","journal-title":"Int J Mol Sci"},{"key":"4569_CR75","first-page":"9009","volume":"10","author":"C Dong","year":"2017","unstructured":"Dong C, Wang X, Xu H, Zhan X, Ren H, Liu Z, et al. Identification of a cytokine-cytokine receptor interaction gene signature for predicting clinical outcomes in patients with colorectal cancer. Int J Clin Exp Med. 2017;10:9009\u201318.","journal-title":"Int J Clin Exp Med"},{"key":"4569_CR76","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/S0960-9776(11)70294-6","volume":"20","author":"M Morales","year":"2011","unstructured":"Morales M, Planet E, Arnal-Estape A, Pavlovic M, Tarragona M, Gomis RR. Tumor-stroma interactions a trademark for metastasis. Breast. 2011;20:S50\u20135.","journal-title":"Breast"},{"key":"4569_CR77","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ygeno.2017.04.005","volume":"109","author":"F Dai","year":"2017","unstructured":"Dai F, Mei L, Meng S, Ma Z, Guo W, Zhou J, et al. The global expression profiling in esophageal squamous cell carcinoma. Genomics. 2017;109:241\u201350.","journal-title":"Genomics"},{"key":"4569_CR78","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/948408","author":"S M\u00fcller","year":"2014","unstructured":"M\u00fcller S, Nowak KJ. Exploring the miRNA-mRNA regulatory network in clear cell renal cell carcinomas by next-generation sequencing expression profiles. BioMed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/948408.","journal-title":"BioMed Res Int"},{"key":"4569_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59337-4","volume":"14","author":"M Soleimani","year":"2024","unstructured":"Soleimani M, Thi M, Janfaza S, Ozcan G, Mazurek S, Ozgun G, et al. Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma. Sci Rep. 2024;14:8603.","journal-title":"Sci Rep"},{"key":"4569_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna6040048","volume":"6","author":"E Dama","year":"2020","unstructured":"Dama E, Melocchi V, Mazzarelli F, Colangelo T, Cuttano R, Di Candia L, et al. Non-coding RNAs as prognostic biomarkers: a miRNA signature specific for aggressive early-stage lung adenocarcinomas. Non-coding RNA. 2020;6:48.","journal-title":"Non-coding RNA"},{"key":"4569_CR81","unstructured":"Li Y-h, Zheng C-r, Liu Y, Wang K, Zhou F-f, Dong X, et al. The role of calcium signaling in organotropic metastasis of cancer. Acta Pharmacologica Sinica. 2025:1\u201312."},{"key":"4569_CR82","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1158\/0008-5472.CAN-12-1875","volume":"73","author":"C Pena","year":"2013","unstructured":"Pena C, C\u00e9spedes MV, Lindh MB, Kiflemariam S, Mezheyeuski A, Edqvist P-H, et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res. 2013;73:1287\u201397.","journal-title":"Cancer Res"},{"key":"4569_CR83","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1038\/onc.2009.253","volume":"28","author":"F Van Zijl","year":"2009","unstructured":"Van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, et al. Hepatic tumor\u2013stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene. 2009;28:4022\u201333.","journal-title":"Oncogene"},{"key":"4569_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-018-1375-9","volume":"16","author":"R Zhang","year":"2018","unstructured":"Zhang R, Zhang T-t, Zhai G-q, Guo X-y, Qin Y, Gan T-q, et al. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis. World J Surg Oncol. 2018;16:1\u201313.","journal-title":"World J Surg Oncol"},{"key":"4569_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15112872","volume":"15","author":"D Martin-Garc\u00eda","year":"2023","unstructured":"Martin-Garc\u00eda D, T\u00e9llez T, Redondo M, Garc\u00eda-Aranda M. Calcium homeostasis in the development of resistant breast tumors. Cancers (Basel). 2023;15:2872.","journal-title":"Cancers (Basel)"},{"key":"4569_CR86","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.tcb.2022.07.004","volume":"33","author":"S Zheng","year":"2023","unstructured":"Zheng S, Wang X, Zhao D, Liu H, Hu Y. Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications. Trends Cell Biol. 2023;33:312\u201323.","journal-title":"Trends Cell Biol"},{"key":"4569_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-024-02541-z","volume":"42","author":"I Khurram","year":"2025","unstructured":"Khurram I, Khan MU, Ibrahim S, Ghani MU, Amin I, Falzone L, et al. Thapsigargin and its prodrug derivatives: exploring novel approaches for targeted cancer therapy through calcium signaling disruption. Med Oncol. 2025;42:1\u201321.","journal-title":"Med Oncol"},{"key":"4569_CR88","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00821-0","volume":"14","author":"Z Bai","year":"2023","unstructured":"Bai Z, Yan C, Chang DJDO. Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer. Discov Oncol. 2023;14:200.","journal-title":"Discov Oncol"},{"key":"4569_CR89","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1158\/1078-0432.CCR-08-0732","volume":"14","author":"CG Kleer","year":"2008","unstructured":"Kleer CG, Bloushtain-Qimron N, Chen Y-H, Carrasco D, Hu M, Yao J, et al. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res. 2008;14:5357\u201367.","journal-title":"Clin Cancer Res"},{"key":"4569_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01933-9","volume":"21","author":"H Deng","year":"2021","unstructured":"Deng H, Hang Q, Shen D, Zhang Y, Chen M. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation. Cancer Cell Int. 2021;21:259.","journal-title":"Cancer Cell Int"},{"key":"4569_CR91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.gene.2016.07.033","volume":"591","author":"LY Sakai","year":"2016","unstructured":"Sakai LY, Keene DR, Renard M, De Backer JJG. FBN1: the disease-causing gene for Marfan syndrome and other genetic disorders. Gene. 2016;591:279\u201391.","journal-title":"Gene"},{"key":"4569_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1158747","volume":"10","author":"Z Guo","year":"2023","unstructured":"Guo Z, Li Z, Chen M, Qi X, Sun Z, Wu S, et al. Multi-omics analysis reveals the prognostic and tumor microenvironmental value of lumican in multiple cancer types. Front Mol Biosci. 2023;10:1158747.","journal-title":"Front Mol Biosci"},{"key":"4569_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.867788","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Shang X, Yang F, Han W, Xia H, Liu N, et al. CDC25C as a predictive biomarker for immune checkpoint inhibitors in patients with lung adenocarcinoma. Front Oncol. 2022;12:867788.","journal-title":"Front Oncol"},{"key":"4569_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01304-w","volume":"20","author":"K Liu","year":"2020","unstructured":"Liu K, Zheng M, Lu R, Du J, Zhao Q, Li Z, et al. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell Int. 2020;20:213.","journal-title":"Cancer Cell Int"},{"key":"4569_CR95","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/CBM-200039","volume":"30","author":"W Cai","year":"2021","unstructured":"Cai W, Ni W, Jin Y, Li Y. TRIP13 promotes lung cancer cell growth and metastasis through AKT\/mTORC1\/c-Myc signaling. Cancer Biomarkers. 2021;30:237-48.\u00a0https:\/\/doi.org\/10.3233\/CBM-200039","journal-title":"Cancer Biomarker"},{"key":"4569_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.839821","volume":"10","author":"Z Wu","year":"2022","unstructured":"Wu Z, Song Y, Wu Y, Ge L, Liu Z, Du T, et al. Identification of KIF23 as a prognostic biomarker associated with progression of clear cell renal cell carcinoma. Front Cell Dev Biol. 2022;10:839821.","journal-title":"Front Cell Dev Biol"},{"key":"4569_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040685","volume":"17","author":"C Zhang","year":"2025","unstructured":"Zhang C, Wu BZ, Thu KL. Targeting kinesins for therapeutic exploitation of chromosomal instability in lung cancer. Cancers. 2025;17:685.","journal-title":"Cancers"},{"key":"4569_CR98","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/19768354.2022.2079718","volume":"26","author":"B Li","year":"2022","unstructured":"Li B, Gu X, Zhang H, Xiong H. Comprehensive analysis of the prognostic value and immune implications of the TTK gene in lung adenocarcinoma: a meta-analysis and bioinformatics analysis. Animal cells and sys. 2022;26:108\u201318.","journal-title":"Animal cells and sys"},{"key":"4569_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03192-2","volume":"24","author":"H Du","year":"2024","unstructured":"Du H, Zhang L, Chen J, Chen X, Qiang R, Ding X, et al. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients. Cancer Cell Int. 2024;24:20.","journal-title":"Cancer Cell Int"},{"key":"4569_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713302","volume":"24","author":"Y Song","year":"2023","unstructured":"Song Y, Kelava L, Kiss I. MiRNAs in lung adenocarcinoma: role, diagnosis, prognosis, and therapy. Int J Mol Sci. 2023;24:13302.","journal-title":"Int J Mol Sci"},{"key":"4569_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143412","volume":"14","author":"S Marconi","year":"2022","unstructured":"Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A, et al. A circulating risk score, based on combined expression of Exo-miR-130a-3p and fibrinopeptide A, as predictive biomarker of relapse in resectable non-small cell lung cancer patients. Cancers. 2022;14:3412.","journal-title":"Cancers"},{"key":"4569_CR102","first-page":"1203","volume":"43","author":"H Tang","year":"2019","unstructured":"Tang H, Lv W, Sun W, Bi Q, Hao Y. miR\u2011505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT\u2011NF\u03baB pathway in NSCLC cells. Int J Mol Med. 2019;43:1203\u201316.","journal-title":"Int J Mol Med"},{"key":"4569_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020111","volume":"11","author":"C Perez-Sanchez","year":"2021","unstructured":"Perez-Sanchez C, Barbarroja N, Pantale\u00e3o LC, L\u00f3pez-S\u00e1nchez LM, Ozanne SE, Jurado-G\u00e1mez B, et al. Clinical utility of microRNAs in exhaled breath condensate as biomarkers for lung cancer. J Pers Med. 2021;11:111.","journal-title":"J Pers Med"},{"key":"4569_CR104","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.7150\/jca.93343","volume":"15","author":"M He","year":"2024","unstructured":"He M, Zhang H, Zhang Y, Ding Y, Zhang F, Kang Y. Systematic analysis to identify the MIR99AHG-has-miR-21-5p-EHD1 CeRNA regulatory network as potential biomarkers in lung cancer. J Cancer. 2024;15:2391.","journal-title":"J Cancer"},{"key":"4569_CR105","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbrc.2018.12.089","volume":"509","author":"W Li","year":"2019","unstructured":"Li W, Cui Y, Wang D, Wang Y, Wang L. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer. Biochem Biophys Res Commun. 2019;509:647\u201356.","journal-title":"Biochem Biophys Res Commun"},{"key":"4569_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.728393","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen S, Wu H, Zhu L, Jiang M, Wei S, Luo J, et al. MiR-199b-5p promotes gastric cancer progression by regulating HHIP expression. Front Oncol. 2021;11:728393.","journal-title":"Front Oncol"},{"key":"4569_CR107","first-page":"4889","volume":"16","author":"A Wu","year":"2018","unstructured":"Wu A, Chen Y, Liu Y, Lai Y, Liu D. miR\u2011199b\u20115p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1. Oncol Lett. 2018;16:4889\u201396.","journal-title":"Oncol Lett"},{"key":"4569_CR108","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-016-0033-6","volume":"5","author":"AJ Favreau","year":"2015","unstructured":"Favreau AJ, McGlauflin RE, Duarte CW, Sathyanarayana P. miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications. Exp Hematol Oncol. 2015;5:4.","journal-title":"Exp Hematol Oncol"},{"key":"4569_CR109","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/apm.12880","volume":"126","author":"SA Dybos","year":"2018","unstructured":"Dybos SA, Flatberg A, Halgunset J, Viset T, Rolfseng T, Kvam S, et al. Increased levels of serum miR\u2010148a\u20103p are associated with prostate cancer. APMIS. 2018;126:722\u201331.","journal-title":"APMIS"},{"key":"4569_CR110","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.7150\/jca.14616","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Deng X, Zeng X, Peng X. The role of Mir-148a in cancer. J Cancer. 2016;7:1233.","journal-title":"J Cancer"},{"key":"4569_CR111","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1002\/jcp.27899","volume":"234","author":"Q Xie","year":"2019","unstructured":"Xie Q, Yu Z, Lu Y, Fan J, Ni Y, Ma L. MicroRNA\u2010148a\u20103p inhibited the proliferation and epithelial\u2013mesenchymal transition progression of non\u2010small\u2010cell lung cancer via modulating Ras\/MAPK\/Erk signaling. J Cell Physiol. 2019;234:12786\u201399.","journal-title":"J Cell Physiol"},{"key":"4569_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108819","volume":"114","author":"D Ge","year":"2019","unstructured":"Ge D, Chen H, Zheng S, Zhang B, Ge Y, Yang L, et al. Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression. Biomed Pharmacother. 2019;114:108819.","journal-title":"Biomed Pharmacother"},{"key":"4569_CR113","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","volume":"64","author":"J Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753\u20136.","journal-title":"Cancer Res"},{"key":"4569_CR114","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.21037\/tcr-20-1240","volume":"9","author":"C Shen","year":"2020","unstructured":"Shen C, Li J, Che G. Prognostic value of let-7 in lung cancer: systematic review and meta-analysis. Transl Cancer Res. 2020;9:6354.","journal-title":"Transl Cancer Res"},{"key":"4569_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21059","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zheng K, Gao Y, Zhao S, Zhao Y, Li W, et al. Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21059.","journal-title":"Heliyon"},{"key":"4569_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39537-0","volume":"13","author":"D Zhu","year":"2023","unstructured":"Zhu D, Qi H, Zhu H. Hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt\/beta-catenin signaling pathway. Sci Rep. 2023;13:12544.","journal-title":"Sci Rep"},{"key":"4569_CR117","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4714931","author":"Y Song","year":"2022","unstructured":"Song Y, Wang Z, He L, Sun F, Zhang B, Wang F. Dysregulation of pseudogenes\/lncRNA\u2010Hsa\u2010miR\u20101\u20103p\u2010PAICS pathway promotes the development of NSCLC. J Oncol. 2022. https:\/\/doi.org\/10.1155\/2022\/4714931.","journal-title":"J Oncol"},{"key":"4569_CR118","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41568-025-00797-9","volume":"25","author":"C Voena","year":"2025","unstructured":"Voena C, Ambrogio C, Iannelli F, Chiarle R. ALK in cancer: from function to therapeutic targeting. Nat Rev Cancer. 2025;25:359\u201378.","journal-title":"Nat Rev Cancer"},{"key":"4569_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194562","volume":"14","author":"A Ashrafi","year":"2022","unstructured":"Ashrafi A, Akter Z, Modareszadeh P, Modareszadeh P, Berisha E, Alemi PS, et al. Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance. Cancers (Basel). 2022;14:4562.","journal-title":"Cancers (Basel)"},{"key":"4569_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.834350","volume":"12","author":"L Mathieson","year":"2022","unstructured":"Mathieson L, O\u2019Connor RA, Stewart H, Shaw P, Dhaliwal K, Williams GO, et al. Fibroblast activation protein specific optical imaging in non-small cell lung cancer. Front Oncol. 2022;12:834350.","journal-title":"Front Oncol"},{"key":"4569_CR121","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20:174\u201386.","journal-title":"Nat Rev Cancer"},{"key":"4569_CR122","doi-asserted-by":"crossref","unstructured":"Kuo C, Giannikou K, Wang N, Warren M, Goodspeed A, Shillingford N, et al. Tumor-associated stroma shapes the spatial tumor immune microenvironment of primary Ewing sarcomas. bioRxiv. 2025:2025.01. 31.635996.","DOI":"10.1101\/2025.01.31.635996"},{"key":"4569_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01611-0","volume":"39","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res. 2020;39:112.","journal-title":"J Exp Clin Cancer Res"},{"key":"4569_CR124","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41416-024-02671-1","volume":"130","author":"L Mathieson","year":"2024","unstructured":"Mathieson L, Koppensteiner L, Dorward DA, O\u2019Connor RA, Akram AR. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome. Br J Cancer. 2024;130:1758\u201369.","journal-title":"Br J Cancer"},{"key":"4569_CR125","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1038\/s41388-022-02453-0","volume":"41","author":"M Hu","year":"2022","unstructured":"Hu M, Bao R, Lin M, Han X-R, Ai Y-J, Gao Y, et al. ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3. Oncogene. 2022;41:4547\u201359.","journal-title":"Oncogene"},{"key":"4569_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06422-5","volume":"23","author":"Y Xie","year":"2025","unstructured":"Xie Y, Wang X, Wang W, Pu N, Liu L. Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges. J Transl Med. 2025;23:386.","journal-title":"J Transl Med"},{"key":"4569_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06079-0","volume":"23","author":"E Nonnast","year":"2025","unstructured":"Nonnast E, Mira E, Ma\u00f1es S. The role of laminins in cancer pathobiology: a comprehensive review. J Transl Med. 2025;23:83.","journal-title":"J Transl Med"},{"key":"4569_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1562115","volume":"15","author":"F Gao","year":"2025","unstructured":"Gao F, Shi H, Wang H, Wang J, Hao D, Fang Y. Extracellular matrix-related genes-based prognostic signature for cervical cancer: association of LAMA4 expression with prognosis and response to immunotherapy. Front Oncol. 2025;15:1562115.","journal-title":"Front Oncol"},{"key":"4569_CR129","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/onc.2016.150","volume":"35","author":"Y Ma","year":"2016","unstructured":"Ma Y, Yu C, Mohamed EM, Shao H, Wang L, Sundaresan G, et al. A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer. Oncogene. 2016;35:6132\u201342.","journal-title":"Oncogene"},{"key":"4569_CR130","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1158\/2326-6066.CIR-24-0532","volume":"13","author":"K Arai","year":"2025","unstructured":"Arai K, Nishito Y, Mizuno H, Motoi N, Hiraoka N, Fuse M, et al. EML4\u2013ALK rearrangement creates a distinctive myeloid cell\u2013dominant immunosuppressive microenvironment in lung cancer. Cancer Immunol Res. 2025;13:1435\u201352.","journal-title":"Cancer Immunol Res"},{"key":"4569_CR131","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jnci\/djac178","volume":"115","author":"T Pellinen","year":"2023","unstructured":"Pellinen T, Paavolainen L, Mart\u00edn-Bernab\u00e9 A, Papatella Araujo R, Strell C, Mezheyeuski A, et al. Fibroblast subsets in non-small cell lung cancer: associations with survival, mutations, and immune features. JNCI J Natl Cancer Inst. 2023;115:71\u201382.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"4569_CR132","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232028","volume":"221","author":"Z Qin","year":"2024","unstructured":"Qin Z, Yue M, Tang S, Wu F, Sun H, Li Y, et al. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. J Exp Med. 2024;221:e20232028.","journal-title":"J Exp Med"},{"key":"4569_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-00296-w","volume":"6","author":"J Ferris","year":"2020","unstructured":"Ferris J, Espona-Fiedler M, Hamilton C, Holohan C, Crawford N, McIntyre AJ, et al. Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer. Cell Death Discov. 2020;6:61.","journal-title":"Cell Death Discov"},{"key":"4569_CR134","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, et al. TTD: therapeutic target database describing target druggability information. Nucleic Acids Res. 2024;52:D1465\u201377.","journal-title":"Nucleic Acids Res"},{"key":"4569_CR135","first-page":"124","volume":"4","author":"M Mac\u00edas-Silva","year":"2010","unstructured":"Mac\u00edas-Silva M, V\u00e1zquez-Victorio G, Hern\u00e1ndez-Dami\u00e1n J. Anisomycin is a multifunctional drug: more than just a tool to inhibit protein synthesis. Curr Chem Biol. 2010;4:124\u201332.","journal-title":"Curr Chem Biol"},{"key":"4569_CR136","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/fcp.12641","volume":"35","author":"H Tan","year":"2021","unstructured":"Tan H, Hu B, Xie F, Zhu C, Cheng Z. Anisomycin sensitizes non\u2010small\u2010cell lung cancer cells to chemotherapeutic agents and epidermal growth factor receptor inhibitor via suppressing PI3K\/Akt\/mTOR. Fundam Clin Pharmacol. 2021;35:822\u201331.","journal-title":"Fundam Clin Pharmacol"},{"key":"4569_CR137","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1095\/biolreprod.109.081729","volume":"82","author":"R Thuillier","year":"2010","unstructured":"Thuillier R, Mazer M, Manku G, Boisvert A, Wang Y, Culty M. Interdependence of platelet-derived growth factor and estrogen-signaling pathways in inducing neonatal rat testicular gonocytes proliferation. Biol Reprod. 2010;82:825\u201336.","journal-title":"Biol Reprod"},{"key":"4569_CR138","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10549-017-4404-4","volume":"166","author":"FR Wilson","year":"2017","unstructured":"Wilson FR, Varu A, Mitra D, Cameron C, Iyer S. Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced\/metastatic breast cancer. Breast Cancer Res Treat. 2017;166:167\u201377.","journal-title":"Breast Cancer Res Treat"},{"key":"4569_CR139","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1182\/blood-2023-174895","volume":"142","author":"SC Nimmagadda","year":"2023","unstructured":"Nimmagadda SC, Patnana PK, Budde PM, Ahmed H, Covey T, Krejsa C, et al. Navtemadlin, a novel MDM2 inhibitor, potentiated venetoclax-induced antitumor efficacy in TP53 wild-type acute myeloid leukemia (AML). Blood. 2023;142:2782.","journal-title":"Blood"},{"key":"4569_CR140","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1158\/1078-0432.CCR-14-0341","volume":"20","author":"L Zimmer","year":"2014","unstructured":"Zimmer L, Barlesi F, Martinez-Garcia M, Dieras V, Schellens JH, Spano J-P, et al. Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS\u2013RAF mutations. Clin Cancer Res. 2014;20:4251\u201361.","journal-title":"Clin Cancer Res"},{"key":"4569_CR141","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1128\/MCB.22.21.7593-7602.2002","volume":"22","author":"AM Delaney","year":"2002","unstructured":"Delaney AM, Printen JA, Chen H, Fauman EB, Dudley DT. Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD 184352. Mol Cell Biol. 2002;22:7593\u2013602.","journal-title":"Mol Cell Biol"},{"key":"4569_CR142","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pharep.2015.08.001","volume":"68","author":"L Kole","year":"2016","unstructured":"Kole L, Sarkar M, Deb A, Giri B. Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-\u03b3 pathway. Pharmacol Rep. 2016;68:144\u201354.","journal-title":"Pharmacol Rep"},{"key":"4569_CR143","first-page":"243","volume":"50","author":"Z Yan","year":"2023","unstructured":"Yan Z, Hao H, Junyi Z, Ting P, Xiaorong D, Ying Y, et al. MDM2 Inhibitor RG-7388 Promotes Apoptosis and Cell Cycle Arrest of Diffuse Large B Cell Lymphoma. Cancer Res Preven Treatment. 2023;50:243\u20138.","journal-title":"Cancer Res Preven Treatment"},{"key":"4569_CR144","first-page":"689","volume":"94","author":"YV Bykov","year":"2022","unstructured":"Bykov YV, Bekker RA. On the specific treatment of asthenic states: focus on sulbutiamine. Ter Arkh. 2022;94:689\u201394.","journal-title":"Ter Arkh"},{"key":"4569_CR145","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/2772432817666220601162006","volume":"19","author":"SA Rizvi","year":"2024","unstructured":"Rizvi SA, Ferrer G, Khawaja UA, Sanchez-Gonzalez MA. Chlorpheniramine, an old drug with new potential clinical applications: a comprehensive review of the literature. Curr Rev Clin Exp Pharmacol. 2024;19:137\u201345.","journal-title":"Curr Rev Clin Exp Pharmacol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04569-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04569-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:56Z","timestamp":1791558116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04569-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":145,"alternative-id":["4569"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04569-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest with the contents of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors reviewed and approved the final version.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work we used language-editing AI tools to improve grammar, spelling, wording, and readability. These tools were used only for linguistic enhancement, ensuring clarity and coherence without altering the scientific content, interpretation, or conclusions. All intellectual contributions, figures and tables, data analyses, and critical discussions remain the work of the authors. After using the tools, we reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}